The University of Queensland

The Development of Human Hematopoietic Prostaglandin D2 Synthase Inhibitors (HPGD2S) For Allergic Asthma (2016–2017)

Grant type:

National Foundation for Medical Research and Innovation

Researchers:

• 

  Associate Professor Mark Smythe

  Principal Research Fellow - GL
  

  Institute for Molecular Bioscience

Funded by:

National Foundation for Medical Research and Innovation